Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia

por Visseren, F. L. J.
Publicado 2011

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill

por Lafeber, M., Spiering, W., Visseren, F. L. J., Grobbee, D. E.
Publicado 2016

Arterial stiffness as a risk factor for cardiovascular events and all‐cause mortality in people with Type 2 diabetes

por Sharif, S., Visseren, F. L. J., Spiering, W., de Jong, P. A., Bots, M. L., Westerink, J.
Publicado 2019

Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells

por Faber, D R, Kalkhoven, E, Westerink, J, Bouwman, J J, Monajemi, H M, Visseren, F L J
Publicado 2012

Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men

por Buddeke, J., Valstar, G. B., van Dis, I., Visseren, F. L. J., Rutten, F. H., den Ruijter, H. M., Vaartjes, I., Bots, M. L.
Publicado 2020

Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus

por de Vries, T. I., Kappelle, L. J., van der Graaf, Y., de Valk, H. W., de Borst, G. J., Nathoe, H. M., Visseren, F. L. J., Westerink, Jan
Publicado 2018

Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial

por Vernooij, J W P, Kaasjager, H A H, van der Graaf, Y, Wierdsma, J, Grandjean, H M H, Hovens, M M C, de Wit, G A, Visseren, F L J
Publicado 2012

A computerised decision support system for cardiovascular risk management ‘live’ in the electronic health record environment: development, validation and implementation—the Utrecht...

por Groenhof, T. K. J., Rittersma, Z. H., Bots, M. L., Brandjes, M., Jacobs, J. J. L., Grobbee, D. E., van Solinge, W. W., Visseren, F. L. J., Haitjema, S., Asselbergs, F. W.
Publicado 2019

Detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score

por Poorthuis, M H F, Morris, D R, de Borst, G J, Bots, M L, Greving, J P, Visseren, F L J, Sherliker, P, Clack, R, Clarke, R, Lewington, S, Bulbulia, R, Halliday, A
Publicado 2021

Cost-effectiveness of a nurse-led internet-based vascular risk factor management programme: economic evaluation alongside a randomised controlled clinical trial

por Greving, J P, Kaasjager, H A H, Vernooij, J W P, Hovens, M M C, Wierdsma, J, Grandjean, H M H, van der Graaf, Y, de Wit, G A, Visseren, F L J
Publicado 2015

The challenge of choosing in cardiovascular risk management

por Hoogeveen, R. M., Hanssen, N. M. J., Brouwer, J. R., Mosterd, A., Tack, C. J., Kroon, A. A., de Borst, G. J., ten Berg, J., van Trier, T., van Lennep, J. Roeters, Liem, A., Serné, E., Visseren, F. L. J., Cornel, J. H., Peters, R. J. G., Jukema, J. W., Stroes, E. S. G.
Publicado 2021